NCT02090933View on ClinicalTrials.gov

Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy Volunteers

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
No Evidence of Disease
Interventions
DRUG

Celecoxib

Given PO

OTHER

Laboratory Biomarker Analysis

Correlative studies

PROCEDURE

UV Light Therapy

Undergo UV-irradiation

Trial Locations (1)

14642

University of Rochester, Rochester

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT02090933 - Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy Volunteers | Biotech Hunter | Biotech Hunter